Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
Автори: | Jayne, DR, Rasmussen, N |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
1997
|
Схожі ресурси
Схожі ресурси
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
за авторством: Mukhtyar, C, та інші
Опубліковано: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
за авторством: Rohini Handa
Опубліковано: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
за авторством: John Chuan Nguyen Tran, та інші
Опубліковано: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
за авторством: Flossmann, O, та інші
Опубліковано: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
за авторством: Brendan L. Thoms, та інші
Опубліковано: (2021-07-01)